Intervention News

Penumbra announced the FDA clearance and launch of its next-generation computer-assisted vacuum thrombectomy system to remove venous thrombus and treat pulmonary emboli.

DENVER —Extracorporeal membrane oxygenation therapy led to favorable survival and neurologic outcomes for patients who required neurosurgical intervention, according to a poster at the American Academy of Neurology annual meeting.

ATLANTA — Use of a coronary sinus reducer improved chest pain symptoms and quality of life for patients with significant coronary artery disease, despite not improving myocardial blood flow, a speaker reported.

ATLANTA — Preventive PCI plus optimal medical therapy was superior to optimal medical therapy alone for patients with nonflow-limiting vulnerable coronary plaques, according to the results of the PREVENT trial.

ATLANTA — In the DanGer-Shock trial, routine use of a microaxial flow pump, on top of standard care, led to a lower risk for death compared with standard care only for treatment of patients with STEMI and cardiogenic shock.

ATLANTA — In a real-world population of patients with severe aortic stenosis at low or intermediate surgical risk, transcatheter aortic valve replacement was noninferior to surgery for death and stroke at 1 year, researchers reported.

ATLANTA — Adults with uncontrolled and treatment-resistant hypertension saw a modest reduction in 24-hour ambulatory BP with alcohol-mediated renal nerve denervation, although other mixed findings complicate the picture, researchers reported.

ATLANTA — In patients with ACS who underwent PCI, ticagrelor monotherapy after 1 month lowered bleeding risk by 55% compared with dual antiplatelet therapy for 12 months, according to the results of the ULTIMATE-DAPT trial.

ATLANTA — In patients with severe aortic stenosis and a small aortic annulus undergoing transcatheter aortic valve replacement, hemodynamic parameters were best with a self-expanding valve, according to data from the SMART trial.

ATLANTA — In patients who underwent early angiography for acute MI and had ejection fraction of 50% or more, long-term beta-blocker use did not reduce risk for death or new MI compared with no use, researchers reported.